LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

LLY

768.74

+0.66%↑

JNJ

154.78

+0.75%↑

ABBV

190.2

+1.33%↑

NVO

74.71

+2.43%↑

UNH

300.13

+0.03%↑

Search

Fulgent Genetics Inc

Отворен

СекторЗдравеопазване

21.46 1.66

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

20.65

Максимум

21.41

Ключови измерители

By Trading Economics

Приходи

-5.7M

-12M

Продажби

-2.8M

73M

EPS

0.04

Марж на печалбата

-16.197

Служители

1,313

EBITDA

-2M

-12M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+15.27% upside

Дивиденти

By Dow Jones

Следващи печалби

1.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

57M

629M

Предишно отваряне

19.8

Предишно затваряне

21.46

Настроения в новините

By Acuity

78%

22%

357 / 380 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Fulgent Genetics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.06.2025 г., 20:45 ч. UTC

Печалби

Broadcom 2Q Sales Climb on Booming AI Demand

5.06.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5.06.2025 г., 23:44 ч. UTC

Пазарно говорене

Gold Edges Higher on Weak U.S. Data -- Market Talk

5.06.2025 г., 23:30 ч. UTC

Пазарно говорене

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5.06.2025 г., 21:32 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

5.06.2025 г., 20:45 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:24 ч. UTC

Печалби

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Rev $15B >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Net $4.97B >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q Adj EPS $1.58 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom 2Q EPS $1.03 >AVGO

5.06.2025 г., 20:15 ч. UTC

Печалби

Broadcom Sees 3Q Rev $15.8B >AVGO

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5.06.2025 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5.06.2025 г., 19:22 ч. UTC

Пазарно говорене

Oil Futures Resume Upward Moves -- Market Talk

5.06.2025 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5.06.2025 г., 18:32 ч. UTC

Пазарно говорене

Gold Slips After Trump-Xi Call -- Market Talk

5.06.2025 г., 18:26 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5.06.2025 г., 18:06 ч. UTC

Пазарно говорене

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5.06.2025 г., 16:30 ч. UTC

Придобивния, сливания и поглъщания

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5.06.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

5.06.2025 г., 16:18 ч. UTC

Пазарно говорене

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5.06.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

5.06.2025 г., 16:12 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

5.06.2025 г., 16:12 ч. UTC

Пазарно говорене

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5.06.2025 г., 16:03 ч. UTC

Пазарно говорене

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5.06.2025 г., 15:49 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Fulgent Genetics Inc Прогноза

Ценова цел

By TipRanks

15.27% нагоре

12-месечна прогноза

Среден 24 USD  15.27%

Висок 25 USD

Нисък 23 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Fulgent Genetics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

1

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

17.32 / 19.04Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Neutral Evidence

Настроение

By Acuity

357 / 380 Класиране в Здравеопазване

Настроения в новините

Много силни мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.